The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis
Open Access
- 1 February 2021
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 203 (3), 339-347
- https://doi.org/10.1164/rccm.202002-0460OC
Abstract
Rationale: Chronic hypersensitivity pneumonitis (CHP) is a condition that arises after repeated exposure and sensitization to inhaled antigens. The lung microbiome is increasingly implicated in respiratory disease, but, to date, no study has investigated the composition of microbial communities in the lower airways in CHP. Objectives: To characterize and compare the airway microbiome in subjects with CHP, subjects with idiopathic pulmonary fibrosis (IPF), and control subjects. Methods: We prospectively recruited individuals with a CHP diagnosis (n = 110), individuals with an IPF diagnosis (n = 45), and control subjects (n = 28). Subjects underwent BAL and bacterial DNA was isolated, quantified by quantitative PCR and the 16S ribosomal RNA gene was sequenced to characterize the bacterial communities in the lower airways. Measurements and Main Results: Distinct differences in the microbial profiles were evident in the lower airways of subjects with CHP and IPF. At the phylum level, the prevailing microbiota of both subjects with IPF and subjects with CHP included Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria. However, in IPF, Firmicutes dominated, whereas the percentage of reads assigned to Proteobacteria in the same group was significantly lower than the percentage found in subjects with CHP. At the genus level, the Staphylococcus burden was increased in CHP, and Actinomyces and Veillonella burdens were increased in IPF. The lower airway bacterial burden in subjects with CHP was higher than that in control subjects but lower than that of those with IPF. In contrast to IPF, there was no association between bacterial burden and survival in CHP. Conclusions: The microbial profile of the lower airways in subjects with CHP is distinct from that of IPF, and, notably, the bacterial burden in individuals with CHP fails to predict survival.This publication has 40 references indexed in Scilit:
- Hypersensitivity PneumonitisAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary FibrosisThe New England Journal of Medicine, 2012
- The human microbiome: at the interface of health and diseaseNature Reviews Genetics, 2012
- Gene-environment interaction in chronic disease: A European Science Foundation Forward LookJournal of Allergy and Clinical Immunology, 2011
- An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaeaThe ISME Journal, 2011
- Topographical Continuity of Bacterial Populations in the Healthy Human Respiratory TractAmerican Journal of Respiratory and Critical Care Medicine, 2011
- QIIME allows analysis of high-throughput community sequencing dataNature Methods, 2010
- Disordered Microbial Communities in Asthmatic AirwaysPLOS ONE, 2010
- Selective progressive response of soil microbial community to wild oat rootsThe ISME Journal, 2008
- ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005American Journal of Respiratory and Critical Care Medicine, 2005